Melanoma Cells
Original Article Targeting STAT3 restores BRAF inhibitor sensitivity through miR-759-3p in human cutaneous melanoma cells
11
IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens
10
The c-Jun/RHOB/AKT pathway confers resistance of BRAF -mutant melanoma cells to MAPK inhibitors
15
miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy
15
A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
17
Polyphenols from green tea inhibit the growth of melanoma cells through inhibition of class I histone deacetylases and induction of DNA damage
13
Ubiquitin ligase UBE3C promotes melanoma progression by increasing epithelial-mesenchymal transition in melanoma cells
9
The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells
14
Uptake of Cystatin by Melanoma Cells in Culture
6
Reprogramming of melanoma cells by embryonic microenvironments
6
B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells
14
Retrovirus Targeting by Tropism Restriction to Melanoma Cells
7
Mitochondrial oxidative phosphorylation controls cancer cell’s life and death decisions upon exposure to MAPK inhibitors
13
Original Article Desmoplastic melanoma involving head and fingers: diagnostic challenges and clinical characteristics
8
PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas
10
Original Article ZFX-mediated down-regulation of FBP1 confers to growth in melanoma
9
Original Article Repression of M-phase phosphoprotein 8 inhibits melanoma growth and metastasis in vitro and in vivo
7
Receptor tyrosine kinases and their activation in melanoma
33
Healthy mitochondria inhibit the metastatic melanoma in lungs
12
Inhibition of Pannexin 1 reduces tumorigenic properties of human melanoma
103